Weightly: Mounjaro Tracker GLP
Weightly is a specialized health-tracking application for GLP-1 medication users on iOS, designed to log injections, symptoms, and weight loss progress.
The App DNA
What makes this app unique?
Users require a dedicated record of medication response and side effects to facilitate discussions with healthcare providers, a need generic diet apps fail to address.
For Individuals prescribed GLP1 medications like Mounjaro, Zepbound, or Ozempic who require structured tracking for weight loss and side effect management.
What does it look like?
Key features
Logs injection date, dosage, and body site for Mounjaro, Zepbound, and Ozempic regimens.
Records side effects and energy levels to identify patterns in medication response.
Charts weight loss metrics against specific GLP1 medication usage timelines.
How much does it cost?
The application is currently free with no identified subscription or in-app purchase tiers, suggesting a lack of clear monetization strategy.
Velocity
Maintenance developmentperformanceShow more...
Weightly: Mounjaro Tracker GLP is currently in a maintenance phase, having shipped only one update in the last 135 days. Development activity is minimal, focusing exclusively on minor bug fixes and performance optimizations rather than new features. Given the lack of recent updates or engagement-driven content, the app's development momentum is stagnant.
Who built it?
DigitalSprout
11 apps tracked · Health & Fitness
Bluetooth Device Finder - Aura
Bluetooth Device Finder - Pod
Throughline: Symptom Tracker
Sober Tracker: Quit Drinking
No Contact Tracker: Unsent
Who Touched My Phone: WTMP
Speaker Cleaner | Water Eject
Mic to Speaker Bluetooth
Revive - Restore Old Photo AI
Weightly - Mounjaro TrackerUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Weightly: Mounjaro Tracker GLP
How's the Health & Fitness market?
Weightly operates as a niche utility in the Health & Fitness category, currently holding a 4.67 rating across 33 reviews. The lack of a clear monetization model or frequent feature updates limits its competitive standing against established health platforms.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Weightly: Mounjaro Tracker GLP
Where is it heading?
The market for GLP-1 management tools is expanding, but Weightly's lack of active development leaves it vulnerable to competitors with better resources. The application must prioritize data portability to remain useful for its target audience, or it will likely be displaced by more comprehensive health platforms.
- The four-month gap in feature development suggests the application is in maintenance mode, which limits its ability to retain users long-term.
- The current focus on GLP-1 specific tracking provides a clear, albeit narrow, value proposition that remains relevant as more patients start these regimens.
The SWOT
- Specialized GLP-1 injection logging creates a high-frequency habit loop
- Exportable symptom reports for healthcare provider consultations
Next best moves
Ship PDF export for symptom journals because users need to share data with providers → increase utility for medical consultations
The counter-intuitive read
The lack of monetization is a strategic liability…
Read the full takeBottom line
Weightly must pivot from a simple tracker to a clinical-support tool by enabling data export, as the current maintenance-only posture fails to capitalize on the high-intent GLP-1 user base.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated